PharmaCyte Biotech, Inc. - COM NEW (PMCB)

Historical Portfolio Holders from Q3 2021 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q2 2024
1.03M
Holdings value Q2 2024
$2.02M
Value change Q2 2024
+$102K
Grand Portfolio weight change Q2 2024
+0%
Number of holders
25
Number of buys Q2 2024
13
Number of sells Q2 2024
-11
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 1.03M $2.02M +$102K $1.96 25
2024 Q1 978K $2.32M -$237K $2.37 27
2023 Q4 1.09M $2.35M +$81.4K $2.16 30
2023 Q3 1.14M $2.4M -$194K $2.10 27
2023 Q2 1.21M $3.47M -$6.63M $2.86 27
2023 Q1 3.53M $10.2M +$392K $2.91 27
2022 Q4 3.39M $9.93M -$3.96M $2.93 28
2022 Q3 4.98M $12M +$2.48M $2.40 22
2022 Q2 3.92M $8.79M +$254K $2.25 23
2022 Q1 3.84M $8.83M +$803K $2.30 20
2021 Q4 3.47M $8.68M +$4.8M $2.50 20
2021 Q3 1.39M $4.42M +$4.42M $3.17 15